Docusign (NASDAQ:DOCU) Price Target Raised to $90.00

Key Points

• Piper Sandler raised Docusign's (NASDAQ:DOCU) target price from $85.00 to $90.00, indicating a potential upside of 18.05%.
• In its latest earnings report, Docusign exceeded analysts' expectations with $800.64 million in revenue, up 8.8% year over year, and a return on equity of 14.27%.
• The company announced a $1.00 billion share buyback program, signaling that management believes its shares are currently undervalued.

Docusign (NASDAQ:DOCU - Free Report) had its price objective boosted by Piper Sandler from $85.00 to $90.00 in a research note released on Friday morning, Marketbeat Ratings reports. Piper Sandler currently has a neutral rating on the stock.

DOCU has been the subject of a number of other reports. UBS Group cut their price objective on Docusign from $85.00 to $80.00 and set a "neutral" rating for the company in a research note on Friday, June 6th. Robert W. Baird dropped their price target on shares of Docusign from $93.00 to $85.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Citigroup increased their price objective on shares of Docusign from $110.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, September 4th. Morgan Stanley lowered their target price on shares of Docusign from $92.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday, June 6th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Docusign from $81.00 to $77.00 and set a "neutral" rating for the company in a report on Friday, June 6th. Four research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $94.14.

Docusign Stock Performance

Shares of DOCU stock traded down $1.93 during mid-day trading on Friday, reaching $79.80. 5,090,202 shares of the company's stock traded hands, compared to its average volume of 2,665,612. The firm has a market capitalization of $16.12 billion, a PE ratio of 60.00, a price-to-earnings-growth ratio of 29.81 and a beta of 1.02. Docusign has a 12 month low of $54.31 and a 12 month high of $107.86. The firm has a 50 day moving average price of $75.61 and a two-hundred day moving average price of $79.29.

Docusign (NASDAQ:DOCU - Get Free Report) last released its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. During the same period in the previous year, the business earned $0.97 earnings per share. Docusign's quarterly revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, equities analysts expect that Docusign will post 1.17 earnings per share for the current fiscal year.

Docusign announced that its Board of Directors has approved a stock repurchase program on Thursday, June 5th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 6.6% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's leadership believes its shares are undervalued.

Insider Transactions at Docusign

In related news, Director Teresa Briggs sold 534 shares of the business's stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $74.37, for a total value of $39,713.58. Following the sale, the director directly owned 8,805 shares in the company, valued at approximately $654,827.85. The trade was a 5.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 15,143 shares of the stock in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $74.80, for a total value of $1,132,696.40. Following the transaction, the chief financial officer directly owned 110,723 shares of the company's stock, valued at approximately $8,282,080.40. The trade was a 12.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 78,552 shares of company stock worth $5,983,631. 1.66% of the stock is currently owned by company insiders.

Institutional Trading of Docusign

Hedge funds have recently modified their holdings of the company. State Street Corp grew its holdings in shares of Docusign by 3.0% in the second quarter. State Street Corp now owns 8,074,976 shares of the company's stock valued at $628,960,000 after purchasing an additional 236,494 shares in the last quarter. American Century Companies Inc. raised its stake in Docusign by 1.6% during the second quarter. American Century Companies Inc. now owns 5,564,318 shares of the company's stock valued at $433,405,000 after purchasing an additional 86,560 shares in the last quarter. Geode Capital Management LLC lifted its position in Docusign by 1.5% during the second quarter. Geode Capital Management LLC now owns 3,985,808 shares of the company's stock valued at $309,910,000 after purchasing an additional 59,941 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Docusign by 18.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,028,505 shares of the company's stock worth $165,120,000 after buying an additional 318,698 shares in the last quarter. Finally, Wellington Management Group LLP grew its stake in shares of Docusign by 372.5% in the 1st quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock worth $148,714,000 after buying an additional 1,440,269 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.